BOLD

Boundless Bio, Inc.

Latest Form 4:Sale$54KbyTANG KEVIN (10% Owner) · filed Aug 28, 2026

Boundless Bio, Inc. (BOLD) has 9 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 28, 2026.

The most active filer is 10% Owner TANG KEVIN with 19 filings. Insiders have net bought $1.4M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Zachary Hornby
  • Employees:64
  • HQ:San Diego, CA, US
  • IPO:2016-07-20

Insider Buying

$1.5M

reported purchases (SEC code P)

Insider Selling

$134K

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$65.1M

latest known value

Source
Sale$54KAug 28SEC ↗
Purchase$647Jul 21SEC ↗
Purchase$4KJul 21SEC ↗
Purchase$7KJul 21SEC ↗
Purchase$107KJul 17SEC ↗
Purchase$4KJul 17SEC ↗
Purchase$45KJul 17SEC ↗
Purchase$17Jul 13SEC ↗
Purchase$105KJul 13SEC ↗
Purchase$117KJul 13SEC ↗
Purchase$67KJul 9SEC ↗
Purchase$39KJul 9SEC ↗
Purchase$35KJul 9SEC ↗
CRANDELL KEITHFirst filing
Sale$40KJul 6SEC ↗
Sale$40KJul 6SEC ↗
Purchase$66KJul 2SEC ↗
Purchase$178KJul 2SEC ↗
Purchase$24KJul 2SEC ↗
Purchase$363KJun 29SEC ↗
Purchase$192KJun 29SEC ↗
Purchase$160KJun 29SEC ↗

Related companies

Boundless Bio, Inc. is in the Healthcare sector.